These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 26047632

  • 1. Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.
    Pesce F, Diciolla M, Binetti G, Naso D, Ostuni VC, Di Noia T, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Di Sciascio E, Schena FP.
    Nephrol Dial Transplant; 2016 Jan; 31(1):80-6. PubMed ID: 26047632
    [Abstract] [Full Text] [Related]

  • 2. Patient classification and outcome prediction in IgA nephropathy.
    Diciolla M, Binetti G, Di Noia T, Pesce F, Schena FP, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Naso D.
    Comput Biol Med; 2015 Nov 01; 66():278-86. PubMed ID: 26453758
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
    Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.
    Nephrology (Carlton); 2016 May 01; 21(5):387-96. PubMed ID: 26393772
    [Abstract] [Full Text] [Related]

  • 4. Prediction of ESRD in IgA Nephropathy Patients from an Asian Cohort: A Random Forest Model.
    Liu Y, Zhang Y, Liu D, Tan X, Tang X, Zhang F, Xia M, Chen G, He L, Zhou L, Zhu X, Liu H.
    Kidney Blood Press Res; 2018 May 01; 43(6):1852-1864. PubMed ID: 30537719
    [Abstract] [Full Text] [Related]

  • 5. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease.
    Komatsu H, Fujimoto S, Kikuchi M, Sato Y, Kitamura K.
    Ren Fail; 2012 May 01; 34(4):448-53. PubMed ID: 22260382
    [Abstract] [Full Text] [Related]

  • 6. Validation of two IgA nephropathy risk-prediction tools using a cohort with a long follow-up.
    Haaskjold YL, Lura NG, Bjørneklett R, Bostad L, Bostad LS, Knoop T.
    Nephrol Dial Transplant; 2023 May 04; 38(5):1183-1191. PubMed ID: 35904322
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease.
    Rauta V, Finne P, Fagerudd J, Rosenlöf K, Törnroth T, Grönhagen-Riska C.
    Clin Nephrol; 2002 Aug 04; 58(2):85-94. PubMed ID: 12227693
    [Abstract] [Full Text] [Related]

  • 8. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
    Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.
    Am J Nephrol; 2015 Aug 04; 41(3):210-9. PubMed ID: 25872002
    [Abstract] [Full Text] [Related]

  • 9. Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.
    Thompson A, Carroll K, A Inker L, Floege J, Perkovic V, Boyer-Suavet S, W Major R, I Schimpf J, Barratt J, Cattran DC, S Gillespie B, Kausz A, W Mercer A, Reich HN, H Rovin B, West M, Nachman PH.
    Clin J Am Soc Nephrol; 2019 Mar 07; 14(3):469-481. PubMed ID: 30635299
    [Abstract] [Full Text] [Related]

  • 10. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
    Liu D, You J, Liu Y, Tang X, Tan X, Xia M, Wu L, Chen G, He L, Zhu X, Liu H.
    Int Immunopharmacol; 2019 Jan 07; 66():13-18. PubMed ID: 30415190
    [Abstract] [Full Text] [Related]

  • 11. Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study.
    Tsunoda R, Usui J, Hoshino J, Fujii T, Suzuki S, Takaichi K, Ubara Y, Yamagata K.
    BMC Nephrol; 2018 Sep 06; 19(1):222. PubMed ID: 30189860
    [Abstract] [Full Text] [Related]

  • 12. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy.
    Schena FP, Anelli VW, Trotta J, Di Noia T, Manno C, Tripepi G, D'Arrigo G, Chesnaye NC, Russo ML, Stangou M, Papagianni A, Zoccali C, Tesar V, Coppo R, members of the VALIGA study.
    Kidney Int; 2021 May 06; 99(5):1179-1188. PubMed ID: 32889014
    [Abstract] [Full Text] [Related]

  • 13. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar 06; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 14. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
    Zhu B, Liu WH, Yu DR, Lin Y, Li Q, Tong ML, Li YY, Yang RC, Du YY, Tang XL, Jiang F, Fei D, Wei XY, Zhang FF, Yin JZ, Wang WR, Li XF, Sun Y, Zhong YZ, Zhang MJ, Cheng XX, Zhu CF, Chen HY.
    Am J Nephrol; 2020 Mar 06; 51(8):624-634. PubMed ID: 32694247
    [Abstract] [Full Text] [Related]

  • 15. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
    Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM.
    Nephrol Dial Transplant; 2002 Jul 06; 17(7):1197-203. PubMed ID: 12105241
    [Abstract] [Full Text] [Related]

  • 16. Serum Uric Acid Level Predicts Progression of IgA Nephropathy in Females but Not in Males.
    Nagasawa Y, Yamamoto R, Shoji T, Shinzawa M, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y, Nakanishi T.
    PLoS One; 2016 Jul 06; 11(8):e0160828. PubMed ID: 27560997
    [Abstract] [Full Text] [Related]

  • 17. Lower serum bilirubin is associated with poor renal outcome in IgA nephropathy patients.
    Jiang Z, Tan J, Wang S, Dong L, Han X, Tang Y, Qin W.
    Int J Med Sci; 2021 Jul 06; 18(13):2964-2970. PubMed ID: 34220324
    [Abstract] [Full Text] [Related]

  • 18. Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy.
    Xu LL, Zhang D, Weng HY, Wang LZ, Chen RY, Chen G, Shi SF, Liu LJ, Zhong XH, Hong SD, Duan LX, Lv JC, Zhou XJ, Zhang H.
    Front Immunol; 2023 Jul 06; 14():1224631. PubMed ID: 37600788
    [Abstract] [Full Text] [Related]

  • 19. Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
    Rehnberg J, Symreng A, Ludvigsson JF, Emilsson L.
    J Am Soc Nephrol; 2021 Feb 06; 32(2):411-423. PubMed ID: 33177116
    [Abstract] [Full Text] [Related]

  • 20. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
    Xie J, Lv J, Wang W, Li G, Liu Z, Chen H, Xu F, Sun J, Ouyang Y, Zhang X, Yang M, Shi M, Zhang W, Ren H, Kiryluk K, Zhang H, Chen N.
    Am J Kidney Dis; 2018 Sep 06; 72(3):371-380. PubMed ID: 29555434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.